January 18, 2008, Newsletter Issue #268: Hormone Replacement Therapy Trial Halted Due to Cancer, Heart Risk

Tip of the Week

Researchers announced July 9, 2002 that they have halted one of the largest and best-designed studies of hormone replacement therapy because women taking the hormones after menopause had a greater risk of breast cancer, heart attack, stroke and blood clots than those who did not take the drugs.

More than 6 million women in the US currently take estrogen/progestin hormone combination therapy for a variety of reasons, including cures of hot flashes and other menopausal symptoms. The hope--and the hype--has been that such hormones would also confer a number of other advantages, including a reduced risk of heart disease. The study suggests that when women take the drugs for more than about 5 years, the risks of the hormones clearly outweigh the benefits.

About LifeTips

Now one of the top on-line publishers in the world, LifeTips offers tips to millions of monthly visitors. Our mission mission is to make your life smarter, better, faster and wiser. Expert writers earn dough for what they know. And exclusive sponsors in each niche topic help us make-it-all happen.

Not finding the advice and tips you need on this Nurse Tip Site? Request a Tip Now!


Guru Spotlight
PJ Campbell